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Abstract
A quantitative mass spectrometry imaging (QMSI) technique using infrared matrix-assisted laser 
desorption electrospray ionization (IR-MALDESI) is demonstrated for the antiretroviral (ARV) 
drug emtricitabine in incubated human cervical tissue. Method development of the QMSI 
technique leads to a gain in sensitivity and removal of interferences for several ARV drugs. 
Analyte response was significantly improved by a detailed evaluation of several cationization 
agents. Increased sensitivity and removal of an isobaric interference was demonstrated with 
sodium chloride in the electrospray solvent. Voxel-to-voxel variability was improved for the MSI 
experiments by normalizing analyte abundance to a uniformly applied compound with similar 
characteristics to the drug of interest. Finally, emtricitabine was quantified in tissue with a 
calibration curve generated from the stable isotope-labeled analog of emtricitabine followed by 
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cross-validation using liquid chromatography tandem mass spectrometry (LC-MS/MS). The 
quantitative IR-MALDESI analysis proved to be reproducible with an emtricitabine concentration 
of 17.2±1.8 μg/gtissue. This amount corresponds to the detection of 7 fmol/voxel in the IR-
MALDESI QMSI experiment. Adjacent tissue slices were analyzed using LC-MS/MS which 
resulted in an emtricitabine concentration of 28.4±2.8 μg/gtissue.
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Introduction
Mass spectrometry imaging (MSI) data is generated by recording mass spectra and the 
corresponding spatial location [1]. Construction of ion heat maps creates a visual 
representation of a compound relating the observed ion abundance with its location. MSI is 
quickly becoming an invaluable tool in drug distribution studies [2–4]. The efficacy of a 
drug can be limited by the ability to reach its intended target; plasma concentrations of a 
drug are often used but may not accurately reflect the concentration of the drug at its site of 
action [5]. Thus, spatial distribution of a drug in tissue can provide vital information related 
to the efficacy of a drug. Moreover, the use of a MSI strategy can provide additional 
information about endogenous compounds and metabolites.
Simultaneous analysis of multiple species while retaining spatial specificity is a challenge 
for current quantitative methods. Selective reaction monitoring (SRM) assays using liquid 
chromatography tandem mass spectrometry (LC-MS/ MS) for quantification of 
pharmaceuticals are commonly used for pharmacokinetic analysis of drugs in plasma and 
tissues [6]. These methods typically require extraction of the analyte from a tissue 
homogenate and result in the loss of spatial information within a tissue or organ. Alternative 
approaches such as quantitative whole body autoradiography (QWBA) or positron emission 
tomography (PET) offer the ability to visualize drug distribution into tissues while providing 
quantitative information [4, 7, 8]. However, QWBA and PET require radiolabeled 
compounds which only give information about the radiolabel and are therefore not able to 
distinguish between the parent compound and its metabolites. Further, these quantitative 
imaging techniques incur significant experimental cost especially in the analysis of multiple 
analytes in multidrug therapies.
Although MSI has proven its utility to provide important spatial information of drugs in 
tissue, quantitative information in MSI has proven difficult to achieve. Matrix-assisted laser 
desorption ionization (MALDI) has been used extensively in qualitative MSI and with some 
success of quantification [1, 7, 9–37]. The recent advances in quantification using MSI were 
the subject of recent review [38]. Quantitative MALDI MSI has several limitations including 
the need for organic matrix deposition for ionization of analytes; the analysis is also 
typically performed under vacuum. Ambient ionization mass spectrometry allows tissues to 
be sampled at conditions much closer to their natural state [39].
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Pixel-to-pixel variability in MSI poses the biggest challenge for quantification [40]. This 
variability can arise from a range of sources, including morphological features, ionization 
efficiency, and detection efficiency. Increasing sensitivity and reducing variability are 
essential steps toward making MSI a routine quantitative technique. Several groups have 
reported various normalization methods to account for tissue-specific signal response and 
reduced variation per pixel [18, 26, 27]. These studies exemplify the need for a suitable 
normalization compound to produce quantitative MSI data. The ideal normalization 
compound accounts for structure-specific ablation and ionization efficiency for the analyte. 
Stable isotope-labeled compounds are the best normalization compounds, as they are 
chemical and structural analogs of the target analyte.
Matrix-assisted laser desorption electrospray ionization (MALDESI) was first presented in 
2006 using a UV laser to resonantly excite an organic matrix with secondary post ionization 
by electrospray ionization (ESI) [41]. Several other reports demonstrate the use of ESI for 
post ionization of a laser ablation plume [42, 43]. The use of a mid-infrared (IR) laser (2.94 
μm) in MALDESI allows the use of endogenous and exogenous ice matrix to be used as a 
matrix, thus simplifying the sample preparation steps and providing spectra without matrix 
peak interference [44]. High fluence of the mid-IR laser allows IR-MALDESI to completely 
ablate through a 10 μm thick tissue section at each rastered position in two laser pulses, 
resulting in the analysis of a voxel of tissue [44]. Recently, the quantitative measurement 
abilities of the secondary ionization source laser electrospray mass spectrometry (LEMS) 
were reported for equimolar and nonequimolar solutions of multiple analytes [45]. LEMS 
was demonstrated to have a monotonic signal response as a function of concentration which 
was similar to ESI.
The need for a reliable method of characterizing spatial distribution of drug therapies within 
tissues, and the advantages of MSI, is exemplified within the field of human 
immunodeficiency virus (HIV). HIV replication has been shown to persist in certain 
anatomic sites such as the lymphatic system and reproductive tract [46, 47]. These viral 
reservoirs represent a significant obstacle in the cure of HIV. Evaluations of antiretroviral 
(ARV) penetration into these reservoirs are critical for understanding whether current 
therapies will be sufficient to completely eliminate HIV from the body. MSI represents a 
promising technique to advance the understanding of within-tissue ARV distribution and to 
provide invaluable information toward the development of drug therapies targeting the HIV 
reservoir.
Herein, we present a quantitative mass spectrometry imaging (QMSI) technique for the 
quantification of emtricitabine, a commonly used ARV [48], in human cervical tissue. Prior 
to quantification, several approaches for enhancing detection of multiple ARV drugs via IR-
MALDESI MSI were evaluated. Tissue or morphologic specific ionization variability was 
then specifically addressed by using normalization compound-coated slides. Increased 
sensitivity and reduced voxel-to-voxel variability subsequently allowed for quantification of 
therapeutically relevant concentrations of emtricitabine in tissue by IR-MALDESI MSI. 
Cross-validation was performed using a validated LC-MS/MS method for adjacent tissue 
slices.
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HPLC grade methanol and water were purchased from Burdick and Jackson (Muskegon, 
MI, USA). Sodium chloride (>99.5 %), silver nitrate (>99 %), potassium chloride (>99.5 
%), formic acid (LC/MS grade), lamivudine (>98 %), acyclovir (>99 %), and prednisolone 
(>99 %) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Emtricitabine (FTC), 
tenofovir (TFV), and raltegravir (RAL) were obtained from the NIH AIDS Reagent 
Program, directed by the Pathogenesis and Basic Research Branch, Basic Sciences Program, 
Division of AIDS (DIADS), NIAID, NIH. 13C15N2-FTC and 13C5-TFV were purchased 
from Moravek Biochemicals (Brea, CA, USA). The structures of the ARV drugs and 
prednisolone are shown in Fig. 1. All materials were used as received without further 
purification.
Tissue samples
Human cervical tissues were obtained from the University of North Carolina Tissue 
Procurement Facility through UNC IRB #09-0921. The tissues were prepared and incubated 
in FTC, TFV, and RAL at a concentration of 100 μg/mL as previously described [49]. 
Tissues were cryosectioned using a Leica CM1950 cryomicrotome (Buffalo Grove, IL, 
USA) to a thickness of 10 μm.
IR-MALDESI imaging
The imaging MALDESI source coupled to the Q Exactive mass spectrometer (Thermo 
Scientific, Bremen, Germany) has been previously described in greater detail [44, 49, 50]. 
Briefly, a tissue section was thaw mounted onto a microscope slide and placed on a XYZ-
controlled Peltier stage. The enclosure surrounding the source was purged with nitrogen 
(MWSC, Raleigh, NC, USA) to less than 3 % relative humidity (RH) prior to the Peltier 
stage being cooled to −9 °C for approximately 10 min. The cooled stage and sample were 
then exposed to the ambient RH in the laboratory air to form a thin ice layer on the sample. 
After a sufficient amount of ice was deposited, the enclosure was purged with nitrogen to an 
approximate RH of 10 % to balance the rate of ice formation and sublimation. Two pulses at 
a repetition rate of 20 Hz from a mid-IR laser λ =2.94 μm (IR-Opolette 2371, Opotek, 
Carlsbad, CA, USA) were used to resonantly excite endogenous and exogenous water on the 
sample causing complete ablation of tissue material. The ablated material from the laser 
pulse is ejected normal to the surface where it interacts with an intersecting ESI plume. The 
neutral species generated in the laser ablation event partition into the charged electrospray 
droplets where they undergo secondary ionization in an ESI-like mechanism [41, 51]. The 
tissue ablation threshold of the laser is approximately 150 μm [52]. The laser was rastered 
across the sample at a spot-to-spot distance of 100 μm using an oversampling technique [44, 
53]. The Q Exactive mass analyzer was fully integrated with IR-MALDESI source and 
synchronized to accumulate ions in the C-trap from both laser pulses prior to a single 
Orbitrap acquisition. The mass range was set to m/z 150–600, with the mass resolving power 
set to RPFWHM=140,000 at m/z 200. High mass measurement accuracy (MMA) within 2 
ppm was achieved using protonated and sodiated adducts of diisooctyl phthalate as two 
internal lock masses at m/z 391.28428 and 413.26623 [54].
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Electrospray ionization cationization agents
The effects of several cationization agents were investigated using cervical tissue incubated 
in ARV drug solution. The incubated tissue was analyzed using 0.2 % formic acid or 30 μm 
solutions of sodium chloride, potassium chloride, or silver nitrate in 50:50 (v/v) methanol/
water as electrospray solvents. Subsequently, 100 nL spots of 4 μg/mL 13C15N2-FTC, 13C5-
TFV, TFV, FTC, RAL, lamivudine (3TC), acyclovir (ACV), and PRED solution were 
pipetted on top of a blank cervical tissue. The analyte spots were analyzed in duplicate with 
electrospray solvents containing 0.2 % formic acid or 0, 10, 20, 30, 40, and 50 μm sodium 
chloride in 50:50 (v/v) methanol/water.
Sample preparation for quantitative MSI
An overview of the quantification workflow using IR-MALDESI MSI is presented in Fig. 2. 
For quantitative MSI, microscope slides were evenly coated with 3TC, ACV, and PRED 
using an automated pneumatic sprayer (TM Sprayer, LEAP Technologies, Carrboro, NC, 
USA). 3TC, ACV, and PRED were selected as internal standards based on their structural 
similarities to the ARV drugs (Fig. 1). The conditions used for evenly coating a microscope 
slide using the TM sprayer are summarized in the Electronic Supplementary Material, Table 
S1. Cryosectioned tissue slices were subsequently thaw mounted onto the coated slides. For 
absolute quantification, a dilution series of 13C15N2-FTC in 50:50 (v/v) methanol/water at 
concentrations of 0, 0.25, 0.5, 1, 2, 4, 6, and 8 μg/mL was pipetted on top of the tissue using 
a modified microliter syringe (Hamilton Company, Reno, NV, USA). One hundred 
nanoliters of each standard solution was used for each calibration spot which covered an 
area approximately 1 mm in diameter on tissue. The absolute quantification was performed 
with five replicates.
Data processing
For generating ion images, the Thermo Fisher RAW files were converted to a mzXML file 
using MSConvert software from Proteowizard [55]. Composite images containing data sets 
from multiple acquisitions were created by converting the RAW file to a mzXL file using 
MSConvert followed by conversion into an imzML file using imzML converter [56]. The 
individual imzML files were then merged into a single master imzML file containing the 
stacked images from multiple experiments. mzXML or imzML file format was loaded into 
and processed in MSiReader, an open source, vendor neutral imaging software [57]. Ion 
abundance maps were created with a bin width of 5 ppm. Centroid values for analytes used 
in determining MMA (Electronic Supplementary Material, Fig. S1) were obtained using 
RawMeat 2.1 (VAST Scientific, Cambridge, MA, USA).
Quantitative IR-MALDESI imaging
All observed FTC and 13C15N2-FTC ion abundances were normalized to the internal 
standard 3TC in MSiReader unless otherwise noted. The concentration of each calibration 
spot was calculated by dividing the total amount of 13C15N2-FTC in picograms by the 
corresponding spot area in square millimeters as determined in MSiReader. The resulting 
calibration points are given as a concentration in picograms per square millimeter. This 
method accounts for variability in spot size from manually spotting the standard on the 
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tissue. The concentration of each calibration point was plotted against the corresponding 
normalized average 13C15N2-FTC/3TC ion abundance ratio. The resulting calibration points 
were fitted with an unweighted linear regression. The average ratio of incubated FTC to 3TC 
over the entire tissue was calculated. The concentration of FTC in tissue was determined 
using the average normalized ion abundance and the 13C15N2-FTC linear regression 
equation. This value represents incubated FTC as a concentration in picograms per square 
millimeter. The FTC concentration was converted to microgram per gram tissue assuming a 
tissue density of 1 mg/mm3 for comparison to LC-MS/MS results.
LC-MS/MS quantification
For each tissue slice analyzed by IR-MALDESI, an adjacent 10 μm thick tissue slice was 
homogenized and analyzed by a validated LC-MS/MS method as previously described [49]. 
LC-MS/MS calibration standards were prepared at 0.3, 0.6, 1.5, 6, 15, 30, 75, 150, 255, and 
300 ng/mL with quality control (QC) samples at 0.9, 21, and 240 ng/mL. The tissue slices 
were homogenized and extracted with 1 mL of solvent; therefore, the final concentration in 
nanograms per milliliter was equivalent to nanogram per tissue slice. The tissue area of the 
adjacent section analyzed by MALDESI QMSI was used to calculate the FTC concentration 
as microgram per gram tissue, assuming a tissue density of 1 mg/mm3. All calibration and 
QC samples were within 10 % of their nominal concentrations.
Results and discussion
Sensitivity enhancement and interference removal
A single incubated cervical tissue was analyzed in four quadrants to compare different 
cationization agents, namely formic acid, NaCl, KCl, and AgNO3. We hypothesized that 
different cationization agents may increase the ionization efficiency and simultaneously 
reduce the variability between spectra. Moreover, the corresponding m/z shift associated 
with different cations can be particularly advantageous in instances where an isobaric 
interference overlaps with the [M+H+]+ analyte peak. Figure 3A shows the optical image of 
the incubated tissue with the cationization agent labeled. The corresponding ion maps of 
FTC, TFV, and RAL with each respective adduct for each quadrant are summarized in Fig. 
3B–D. The sodium adduct of the three incubated drugs is detected with higher ion 
abundance and with less variability than any of the other cationization agents (Electronic 
Supplementary Material, Table S2). The largest gain in detected ion abundance is observed 
for the detection of RAL, with nearly an order of magnitude increase. The high affinity of 
RAL toward sodium cations is attributed to its molecular structure (Fig. 1). RAL is 
classified as an integrase inhibitor, all of which share two common structural features: a 
hydrophobic benzyl moiety and a chelating triad to bind to two Mg2+ ions [58]. RAL is 
suspected to chelate sodium ions in a similar manner since Na+ and Mg2+ have a similar 
ionic radius. The formation of two Na+ adducts was negligible at the concentrations studied 
here (data not shown). Based on the improved response across all ARVs, NaCl was doped 
into the electrospray solvent for all subsequent experiments.
To further optimize the cationization conditions, the concentration of the sodium chloride in 
the electrospray solvent was systematically varied from 0 to 50 μm in 10 μm increments 
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using a series of ARV calibration spots of the same concentration. In addition, two spots 
were analyzed with 0.2 % formic acid for comparison to the previously optimized 
conditions. Ion maps of the protonated and sodiated molecules of 13C15N2-FTC are shown 
in Fig. 4. The [M+H+]+ to [M+ Na+]+ ratio decreased with increasing concentration of NaCl 
in solution as expected from competing ionization. However, a maximum [13C15N2-FTC
+Na+]+ ion abundance occurred at 30 μm. This maximum at 30 μm NaCl was consistent for 
all compounds in the solution (data not shown). Figure 4 also highlights the removal of an 
isobaric interference from the analyte. The protonated form of stable isotope-labeled (SIL) 
FTC, [13C15N2-FTC+H+]+, had an isobaric interference which makes identification and 
quantification at low concentrations difficult. In contrast, the sodium adduct of the 
compound was free from this interference. Based on these results, 30 μm NaCl in 50:50 
methanol/water was used for the quantification of the incubated tissues.
Normalization strategy
The QMSI calibration curve presented (Fig. 7) used the stable isotope-labeled analog to 
quantify the analyte. In the present study, a different but structurally similar compound was 
used as an internal standard to account for voxel-to-voxel variation because the SIL-FTC is 
being used for quantification. Fortunately, several structural analogs mimicking a specific 
nucleotide have been synthesized for use in ARV therapy. 3TC and FTC are cytosine 
analogs, while ACV and TFV are guanosine and adenosine analogs, respectively. The 
analytes and their respective normalization compounds are shown in Fig. 1.
The incorporation of a structurally similar normalization compound allows for the 
normalization of analyte ion abundances on a per voxel basis. It is important to note that the 
laser in IR-MALDESI experiments completely ablates all tissue material from each location 
to ensure the same amount of material is sampled at each position in the oversampling 
method used. This complete ablation also allows the use of internal standard to be placed 
under the tissue in the analysis and still be effectively sampled. Variability between IR-
MALDESI response to standards spotted above and below tissue has been demonstrated to 
be less than 17 % (Electronic Supplementary Material, Fig. S2). 3TC, ACV, and PRED were 
evenly sprayed on a microscope slide at approximately 90 fmol/voxel prior to thaw 
mounting a 10 μm thick incubated tissue section.
Figure 5 shows the ion maps used in the normalization strategy presented. Figure 5A shows 
the absolute ion abundance for the sodium adduct of the incubated FTC, while Fig. 5B 
depicts the absolute ion abundance for the sodium adduct of the normalization compound, 
3TC. The normalized ion map in Fig. 5C is created by taking the ratio of analyte to 
normalization compound at each voxel. The inclusion of a normalization compound has 
been previously shown to account for tissue-specific analyte response in MSI [26–28].
The complete ablation of the sample at each position is a major advantage over MALDI-
based MSI techniques where compounds placed below the tissue may be incorporated at a 
lesser extent due to extraction into the tissue and then into the organic matrix used in 
MALDI analyses. Similarly, compounds placed on top of the tissue may be incorporated to a 
greater extent than compounds within the tissue, representing a surface concentration and 
not an in-tissue concentration. The extraction of compounds into the organic matrix is seen 
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to be one of the biggest sources of variability in MALDI MSI analysis. IR-MALDESI 
proves to circumvent most of these issues with the complete ablation of tissue at each spatial 
location. Therefore, each pixel in the ion maps actually represents a volume element of 
tissue and should be referred to as a voxel.
This work here is performed on a single tissue type, cervical, which was assumed to be 
relatively homogeneous in composition. Also, the incubation method used in distributing the 
compound within the tissue is assumed to be homogeneous. Finally, the internal standard 
was evenly applied using an automatic pneumatic sprayer and assumed to be 
homogeneously distributed. These assumptions allow us to develop a normalization strategy 
in order to reduce signal variability across the entire tissue. A consistent detected abundance 
would be optimal. The use of sodium cationization along with normalization to an evenly 
incorporated internal standard was able to reduce the voxel %RSD for the entire tissue from 
56 % for [FTC+H+]+ (Fig. 5B) to 32 % for [FTC+ Na+]+/[3TC+Na+]+ (Fig. 5C). Although 
RAL and PRED are not structurally related, normalization of RAL to PRED produces an 
image with reduced variability per voxel, indicating similar extraction and ionization 
efficiencies. The images generated for TFV and RAL using the absolute abundance and with 
the normalization to their internal standard applied are shown in Electronic Supplementary 
Material, Fig. S3.
Accounting for ionization efficiency per voxel
The normalization method presented in Fig. 5 shows a significant improvement in the 
observed analyte heat map and a corresponding reduction in voxel %RSD. The 30 μm NaCl 
electrospray solvent produces both [M+H+]+ and [M+Na+]+ ions (Fig. 4) through competing 
ionization mechanisms. Since we know the amount of material ablated at each voxel is 
consistent, we are able to compare the competing protonation and sodiation processes on a 
per spectrum basis in a single experiment. Figure 6A, B shows the absolute ion abundances 
associated with the sodiated and protonated adducts, respectively. The ion maps show 
localized areas of higher ion abundance commonly referred to as hot spots in the MALDI 
community. An interesting result occurs when the analyte ion abundance is normalized to 
the competing cationization of the normalization compound (Fig. 6C, D). The images are 
visibly more heterogeneous, a statement that is supported by the increased corresponding 
voxel %RSD values for the normalized heat maps. The resulting differences in the ion maps 
are the direct result of the competing ionization efficiencies of protonation and sodiation. If 
the analyte is normalized to the normalization compound having the same adduct, the voxel-
to-voxel %RSD values are significantly improved. This result is independent of which 
ionization mechanism, protonation or sodiation, is applied to the analyte and internal 
standard. This is evidence demonstrating that the internal standard is truly accounting for 
ionization efficiency per spectrum (voxel), which is crucial to reducing variability that 
prevents per voxel quantification in MSI.
Quantification of emtricitabine using MALDESI QMSI
The calibration curves for the MSI experiment were generated using the SIL analog of the 
analyte. This method allows for correction of tissue-specific response by placing the 
calibration curve directly on the analyzed tissue. The use of SIL calibration spots also allows 
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a direct comparison of analyte to the calibration curve, avoiding the use of a standard 
addition calibration curve. The accuracy and sensitivity of a standard addition curve may be 
adversely affected by the high voxel-to-voxel variability in MSI.
Calibration spots were placed on top of the tissue using the SIL analog of FTC. To account 
for variations in spot size, the concentration of the standard per area was calculated for each 
calibration level separately. This was seen to effectively reduce variability due to the area of 
the calibration spots. The concentration was then plotted against the average ratio of SIL-
FTC to 3TC to generate the calibration curves for the five QMSI replicates. Construction of 
interday calibration curves leads to differences in sensitivity as represented by variability in 
the slope of the calibration curve. This may be due to a variety of interday differences 
including the amount and composition of ambient ions, electrospray stability, or long-term 
stability of analyte and normalization compounds. Nonetheless, the average ratio of 
incubated FTC to internal standard 3TC of the entire tissue can be taken, related back to the 
SIL-FTC calibration curves generated to give a tissue average concentration in picograms 
per square millimeter. The total area of the tissue is known from the MSI analysis in 
MSiReader, which in conjunction with the calculated concentration can give the amount of 
FTC in the tissue slice. A representative calibration curve is shown in Fig. 7.
The average tissue concentration calculated from the calibration curves is given per 1 mm2, 
which allows for the direct comparison of the five samples. The average FTC tissue 
concentration of 172.0±17.4 pg/mm2 (±95 % CI, n=5) calculated from the IR-MALDESI 
QMSI analysis indicates good agreement between QMSI replicates. The total amount of 
drug in the tissue slice was calculated using the total area and its corresponding 
concentration. To allow comparison of QMSI to LC-MS/MS data for all replicates, the 
concentration of FTC was given as micrograms per gram tissue. The average FTC tissue 
concentration was 17.2 ± 1.8 μg/gtissue for IR-MALDESI QMSI data. Relative to LC-
MS/MS, IR-MALDESI detection of FTC on a per voxel basis requires significantly higher 
sensitivity since the sample volume is greatly reduced. This spatial information provides 
important insight into the distribution of the compound but challenges instrument detection 
limits. The QMSI data presented represents the detection limit of the compound at 
approximately 7 fmol/voxel.
Comparison to LC-MS/MS
Ultimately, the IR-MALDESI QMSI experiment was cross-validated using a SRM LC-
MS/MS assay on adjacent slices of the incubated tissue. The overall size of the tissue 
changed by approximately 20 % over the course of sectioning the irregularly shaped tissue. 
This change in tissue size can be correlated to a change in absolute amount of tissue 
analyzed and must be compensated for in the comparison of intra-LC-MS/MS analyses and 
the IR-MALDESI QMSI analyses. The average tissue FTC amount was 28.4±2.8 μg/gtissue 
based on LC-MS/MS data. Summary of the QMSI and LC-MS/MS results are presented in 
Table 1. FTC concentrations obtained from IR-MALDESI QMSI and LC-MS/MS analyses 
are in good agreement with each other; however, they are not within the error of either 
measurement. As previously discussed, IR-MALDESI completely ablates the entire volume 
of tissue present at a given ablation spot, such that the difference is not likely to be solely 
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attributable to a surface vs. volume concentration difference as often seen in MALDI MSI. 
Further work will be conducted to understand the source of any systematic error between 
these two methods.
Conclusion
A new approach for IR-MALDESI QMSI was demonstrated for the HIV drug FTC present 
in incubated cervical tissue. Sodium cationization was used to increase ion abundance and 
remove isobaric interference. A normalization compound was selected based on molecular 
structure and implemented during QMSI. Normalization led to reduced signal variability 
providing higher quality images and demonstrated improvements toward a per voxel 
quantification strategy. The total amount of FTC in tissue was 17.2±1.8 μg/gtissue for IR-
MALDESI QMSI and 28.4±2.8 μg/gtissue based on LC-MS/MS data. The IR-MALDESI 
QMSI analyses represent the detection of FTC at approximately 7 fmol/voxel.
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Structures of the targeted analytes. Emtricitabine (FTC) and lamivudine (3TC) are 
nucleoside reverse transcriptase inhibitors (NRTIs) and are cytosine analogs. Tenofovir 
(TFV) and acyclovir (ACV) are also NRTIs and are adenosine and guanosine analogs, 
respectively. Raltegravir (RAL) belongs to the HIV integrase inhibitor class of ARV drugs. 
Although not structurally similar, prednisolone (PRED) was used as an internal standard for 
RAL
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Workflow for quantitative IR-MALDESI MSI
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Cervical tissue incubated in 100 μg/mL ARV drug solution was analyzed using 0.2 % formic 
acid [M+H+]+, 30 μm sodium chloride [M+ Na+]+, 30 μm potassium chloride [M+K+]+, or 
30 μm silver nitrate [M+107Ag+]+ in 50:50 methanol water ESI solution. (A) Optical image 
of the tissue before exogenous ice matrix formation and ion maps for incubated (B) 
emtricitabine, (C) tenofovir, and (D) raltegravir
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Composite image demonstrating the ionization effects of several concentrations of sodium 
chloride and 0.2 % formic acid in the ESI solvent. A solution containing all the ARV in the 
study was pipetted onto a blank tissue to determine optimum selectivity and sensitivity. The 
ion map of 13C15N2-FTC is shown to exemplify the use of 30 μm sodium chloride in the ESI 
solvent to remove isobaric interference and increase sensitivity
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Visualization of the normalization process used to reduce variability at a per voxel basis of 
tissue replicate 2. Ion maps of (A) the absolute ion abundance of analyte [FTC+ Na+]+, (B) 
absolute ion abundance of normalization compound [3TC+Na+]+, (C) ratio of analyte to 
internal standard [FTC+Na+]+/[3TC+Na+]+
Bokhart et al. Page 18














Ion maps comparing the ionization efficiencies of protonation and sodiation adducts of FTC. 
The ion map and %RSD for the entire tissue are shown for (A) [FTC+Na+]+ and (B) [FTC
+H+]+ representing the detected ion abundance of FTC. The normalization of FTC to the 
competing ionization mechanism of internal standard for (C) [FTC+Na+]+/[3TC+H+]+ and 
(D) [FTC+H+]+/[3TC+Na+]+. The %RSD per pixel increases in both cross normalizations 
and the ion maps are visually more heterogeneous. Normalization of the analyte and internal 
standard with the same adduct produces the lowest pixel %RSD and improved visual quality 
for both the (E) sodiated and (F) protonated adducts
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Summary of FTC quantification of tissue section 4. (A) Ion map of [FTC+Na+]+/[3TC
+Na+]+ representing abundance of incubated FTC in the tissue section. The average ratio 
was 0.728. (B) Ion map of [13C15N2-FTC+Na+]+/[3TC+Na+]+ representing the calibration 
curve at 0, 0.25, 0.5, 1, 2, 4, 6, and 8 μg/mL solution. (C) Resulting calibration curve 
generated from 13C15N2-FTC showing good linearity with R2= 0.9973. The calculated tissue 
concentration was near the center of the calibration range. (D) Summary of values used to 
generate the total amount of drug present in tissue section. Using the average ratio and the 
equation of the calibration curve returns a value of the FTC concentration in tissue in 
picograms per square millimeter. Using the area of the tissue, the total amount of FTC in the 
section was determined to be 24.0 ng
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